Tumor Necrosis Factor Ligand Superfamily Member 2 (UF)
tumor nekrotizující faktor alfa (UF)
See also
glykoproteiny
krevní proteiny
monokiny
tumor nekrotizující faktory
adalimumab (RT)
certolizumab pegol (RT)
infliximab (RT)
Linking entry
Tumor Necrosis Factor-alpha
Conspect
D09. - 400. - 430. - 965
D12. - 644. - 276. - 374. - 500. - 800
D12. - 644. - 276. - 374. - 750. - 626
D12. - 776. - 124. - 900
D12. - 776. - 395. - 930
D12. - 776. - 467. - 374. - 500. - 800
D12. - 776. - 467. - 374. - 750. - 626
D23. - 529. - 374. - 500. - 800
D23. - 529. - 374. - 750. - 626
Note
Serum glycoprotein produced by activated MACROPHAGES and other mammalian MONONUCLEAR LEUKOCYTES. It has necrotizing activity against tumor cell lines and increases ability to reject tumor transplants. Also known as TNF-alpha, it is only 30% homologous to TNF-beta (LYMPHOTOXIN), but they share TNF RECEPTORS.
Database
MESH
References
(9) - MESH
subject heading
Number of the records: 1
openseadragon
This site uses cookies to make them easier to browse. Learn more about
how we use cookies.